The medical uses of manosonic nebulizers (AMSA®) in 2018.

Fieux, M; Mélan, J-B; Hermann, R; Truy, E; Tringali, S

Fieux, M; Mélan, J-B; Hermann, R; Truy, E; Tringali, S.

Afiliação

Fieux M; Service d'Otologie et Otoneurologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Université de Lyon, Université Claude Bernard Lyon 1, 69495, Pierre-Bénite, France. Electronic address: maxime.fieux@chu-lyon.fr.
Mélan JB; Service d'Otologie et Otoneurologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Université de Lyon, Université Claude Bernard Lyon 1, 69495, Pierre-Bénite, France.
Hermann R; Service ORL et Chirurgie Cervico-Faciale, Hospices Civils de Lyon, Centre Hospitalier Lyon, Hôpital Edouard Herriot, Lyon, France.
Truy E; Service ORL et Chirurgie Cervico-Faciale, Hospices Civils de Lyon, Centre Hospitalier Lyon, Hôpital Edouard Herriot, Lyon, France.
Tringali S; Service d'Otologie et Otoneurologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Université de Lyon, Université Claude Bernard Lyon 1, 69495, Pierre-Bénite, France.

Eur Ann Otorhinolaryngol Head Neck Dis ; 138(2): 73-76, 2021 Mar.

Article em En | MEDLINE | ID: mdl-32674996

Assuntos

Amsacrina; Tuba Auditiva; França; Humanos; Nebulizadores e Vaporizadores; Estudos Prospectivos

Palavras-chave

Eustachian tube dysfunction; Manosonic nebulizer; Myringotomy tube; Nebulizer; Serous or seromucous otitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amsacrina / Tuba Auditiva Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google